AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
2001

Blocking a receptor reduces brain tumor growth

publication Evidence: moderate

Author Information

Author(s): Rivera E, Arrieta O, Guevara P, Duarte-Rojo A, Sotelo J

Primary Institution: Neuroimmunology Unit, National Institute of Neurology and Neurosurgery of Mexico

Hypothesis

Does blocking the AT1 receptor reduce the growth of glioma cells?

Conclusion

Blocking the AT1 receptor with Losartan significantly reduces the growth of glioma cells.

Supporting Evidence

  • Losartan induced a 79% reduction of tumor volume.
  • There was a significant decrease in vascular density, mitotic index, and cell proliferation.

Takeaway

A medicine called Losartan can help shrink brain tumors by blocking a specific receptor.

Methodology

The study examined the effect of Losartan on C6 glioma cells in rats.

Participant Demographics

C6 glioma cells in rats

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1054/bjoc.2001.2102

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication